Advertisement

Effect of Estrogen on Serum and Tissue Levels of Copper and Zinc

  • Sudha W. Mehta
  • Renee’ Eikum

Abstract

Estrogen along with progestogen is the most widely used form of contraceptive by women. Its use in any dose, form or route has been shown to increase serum copper and ceruloplasmin levels in humans and rats. However, its effect on plasma zinc levels is not established unequivocally. We demonstrated in female Long-Evans-Hooded rats that 4 weeks after implantation with 17 ß-estradiol their serum copper and ceruloplasmin and brain copper levels increased while hepatic copper levels decreased significantly. Kidney copper levels increased transitorily after 2 weeks but not after 4 weeks. Zinc levels were affected only in the liver of these animals. It may be concluded that estrogen therapy depletes hepatic stores of these elements with abnormal accumulation of copper in the brain. Health implications of these changes need further investigation.

Keywords

Zinc Level Copper Level Estrogen Treatment Serum Copper Serum Zinc Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Briggs, M.; Austin, J.; Staniford, M. Oral Contraceptives and Copper Metabolism. Nature 1970, 225, 81.Google Scholar
  2. Cartwright, G.E. Copper Metabolism. John Hopkins University Press, Baltimore, 1950.Google Scholar
  3. Cohen, D.I.; Illowsky, B.; Linder, M.C. Altered copper absorption in tumor bearing and estrogen-treated rats. Am. J. Physiol. 1979, 236, E309–E315.Google Scholar
  4. Crews, M.G.; Taper, L.J.; Ritchey, S.J. Effects of oral contraceptive agents on copper and zinc balance in young women. Am. J. Clin. Nutr. 1980, 33, 1940–1945.PubMedGoogle Scholar
  5. Evans, G.E.; Cornatzer, N.F.; Cornatzer, W.E. Mechanism for hormone-induced alterations in serum ceruloplasmin. Am. J. Physiol. 1970, 218, 613–615.PubMedGoogle Scholar
  6. Feller, D.J.; O’Dell, B.L. Dopamine and norepinephrine in discrete areas of copper-deficient rat brain. J. Neurochem. 1980, 343, 1259–1263.Google Scholar
  7. Flynn, A.; Estrogen modulation of blood copper and other essential metal concentrations. In: Inflammatory Diseases and Copper; Sorensen, J.R., Ed.; Humana Press, Clifton, NJ, 1982.Google Scholar
  8. Garofalo, J.A.; Ashikari, H.; Lesser, M.L.; Menendez-Botet, C.; Cunningham-Rundles, S.; Schwartz, M.K.; Good, R.A. Serum zinc, copper and the Cu/Zn ratio in patients with benign and malignant breast lesions. Cancer 1980, 46, 2682–2685.Google Scholar
  9. Held, N.A.; Burgel, N.; Wilson, CA.; Monsen, E.R. Constancy of zinc and copper status in adult women consuming diets varying in ascorbic acid and phytate content. Nut. Rep. Int. 1988, 37, 1308–1317.Google Scholar
  10. Henkin, R.I.; Palten, B.M.; Re, P.K.; Bronzert, D.A. A syndrome of acute zinc loss. Arch. Neurol. 1975, 32, 745–751.PubMedGoogle Scholar
  11. Hesse, 0.; Hesse, K.A.F.; Catalanotto, F.A. Behavioral characteristics of rats experiencing chronic zinc deficiency. Physiol. Behav. 1979,22, 211–215.PubMedCrossRefGoogle Scholar
  12. Hinks, L.J.; Clayton, B.E.; Lloyd, R.S. Zinc and copper concentrations in leukocytes and erythrocytes in healthy adults and the effect of oral contraceptives. J. Clin. Pathol. 1983, 36, 1016–1021.PubMedCrossRefGoogle Scholar
  13. Kay, CR. The Royal College of General Practitioner’s Oral Contraception Study; some recent observations. Clinics in obstet, and gyne. 1984, 11,759–786.Google Scholar
  14. King, J.C.; Raynolds, W.L.; Margen, S. Absorption of stable isotopes of iron, copper, and zinc during oral contraceptive use. Am. J. Clin. Nutr. 1978, 31, 1198–1203.PubMedGoogle Scholar
  15. King, J.C. Do women using oral contraceptive agents require extra zinc? J. Nutr. 1987, 117, 217–219.PubMedGoogle Scholar
  16. Lei, K.Y.; Prasad, A.S.; Bowersox, E.; Oberleas, D. Oral contraceptive, norethindrone and westranol: effects on tissue levels of minerals. Am. J. Physiol. 1976, 231, 98–103.PubMedGoogle Scholar
  17. Margen, S.; King, J.C. Effect of oral contraceptive agents on the metabolism of some trace minerals. Am. J. Clin. Nutr. 1975, 28, 392–402.PubMedGoogle Scholar
  18. Mcbean, L.D.; Smith, J.C, Jr.; Halsted, J.A. Effect of oral contraceptive hormones on zinc metabolism in the rat. Proc Soc. Ecp. Biol. Med. 1971, 137, 543–547.Google Scholar
  19. Meyer, B.J.; Meyer, A.C.; Horwitt, M.K. Factors influencing serum copper and ceruloplasmin oxidative activity in the rat. Am. J. Physiol. 1958, 194, 581–584.PubMedGoogle Scholar
  20. Prasad, A.S.; Oberleas, D.; Lei, K.Y.; Moghissi, K.S.; Stryker, J.C. Effect of oral contraceptive agents on nutrients: I. Minerals. Am. J. Clin. Nutr. 1975, 28, 377–384.Google Scholar
  21. Prema, K.; Ramalakshmi, B.A.; Babu, S. Serum copper and zinc in hormonal contraceptive users. Fest and Ster. 1980, 33, 267–271.Google Scholar
  22. Schosinsky, K.H.; Lehmann, H.P.; Beeler, M.F. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-odianisidine dihydrochloride. Clin. Chem. 1974, 20, 1556–1560.PubMedGoogle Scholar
  23. Vir, S.C.; Love, A.H. Zinc and copper nutriture of women taking oral contraceptive agents. Am. J. Clin. Nutr. 1981, 34, 1479–1483.PubMedGoogle Scholar
  24. Yunice, A.A.; Lindeman, R.D. Effect of estrogen-progesterone administration on tissue cation concentrations in the rat. Endocrinology 1975, 97, 1263–1269.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Sudha W. Mehta
    • 1
  • Renee’ Eikum
    • 1
  1. 1.Department of Human and Family ResourcesNorthern Illinois UniversityDeKalbUSA

Personalised recommendations